Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07458971

ICF-Based Biopsychosocial Assessment With AI-Assisted Profile Prediction: Trapeziometacarpal Osteoarthritis Model

Trapeziometacarpal osteoarthritis (TMC OA) is a common condition affecting the base of the thumb that causes pain, weakness, and difficulty with daily hand use. Current clinical assessment often focuses on physical findings alone, without considering psychological and social factors that also influence patient outcomes.

This study has three objectives organized as interrelated work packages:

OBJECTIVE 1 (Clinical Assessment): To comprehensively assess individuals with TMC OA using the International Classification of Functioning, Disability and Health (ICF) framework. This includes evaluating pain, joint mobility, grip strength, daily activity limitations, social participation, psychological factors (anxiety, depression, fear of movement, pain beliefs), and environmental factors (family support, ergonomic adaptations).

OBJECTIVE 2 (AI Knowledge Evaluation): To compare the medical knowledge performance of four large language models (Claude, ChatGPT, Gemini, LLaMA) in answering clinical questions about TMC OA, using criteria such as accuracy, reproducibility, comprehensiveness, clinical relevance, and readability.

OBJECTIVE 3 (AI-Based Prediction): To analyze whether the best-performing large language model can predict multidimensional ICF-based patient profiles using only a limited set of core clinical parameters.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

25 year–74 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Hacettepe University, Faculty of Physical Therapy and Rehabilitation, Hand Surgery Rehabilitation Unit

Ankara, Turkey (Türkiye)

Location contact

Tugba Ulusoy, MSc

CONTACT

[email protected]

+90 5075097351

About this study

This research consists of three independent but interrelated work packages with different methods and targets.

Work Package 1 (Clinical Data Collection and ICF-Based Profile Analysis): Participants with TMC OA will undergo a single face-to-face comprehensive assessment using a cross-sectional design. The assessment battery is structured according to the ICF framework and covers five domains: (a) Body Structure/Function: pain, joint mobility, grip and pinch strength, joint stability, and OA staging; (b) Activity: daily activity limitations and pain-activity patterns (avoidance, overdoing, pacing); (c) Participation: social, domestic, and occupational participation; (d) Personal Factors: pain beliefs, coping strategies, kinesiophobia, anxiety, and depression; (e) Environmental Factors: family support and ergonomic adaptations.

Work Package 2 (Comparison of Large Language Models' Clinical Knowledge Performance): Four large language models (Claude, ChatGPT, Gemini, LLaMA) will be queried with questions frequently encountered in the TMC OA domain. Responses will be evaluated by subject matter experts using five criteria: accuracy, reproducibility (same questions repeated two times), comprehensiveness, clinical relevance, and readability (health literacy appropriateness).

Work Package 3 (LLM-Based Predictive Profile Modeling): The best-performing LLM identified in WP2 will be provided with core clinical predictors from WP1 data. The model's predictions for multidimensional ICF-based patient profiles will be compared against actual assessment results using established agreement and performance metrics.

Sample size: Based on a priori power analysis (alpha=0.05, power=0.80, effect size=0.131), a minimum of 93 participants is required.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of trapeziometacarpal osteoarthritis (TMC OA) confirmed by an orthopedic surgeon and/or hand surgeon
  • TMC OA-related symptoms persisting for more than 3 months
  • Aged between 25 and 74 years
  • Literate in Turkish
  • Adequate cognitive function (Mini-Mental State Examination score of 25 or above)
  • No other chronic systemic disease (e.g., rheumatoid arthritis, chronic diabetes, cardiovascular disease, chronic hepatitis)
  • Voluntary participation with signed informed consent

Exclusion criteria

  • Unwillingness to participate
  • Presence of a different orthopedic condition or prior surgery involving the thumb on the unilateral upper extremity
  • Uncontrolled systemic diseases (chronic obstructive pulmonary disease, congestive heart failure, endocrine system disease, history of stroke)
  • Diagnosis of any major psychopathology and currently receiving psychiatric or psychological treatment
  • Pregnancy

Treatment and study plan

Primary outcomes

  1. Grip Strength

    Time frame: Baseline (single assessment at enrollment)

    Measured using a Jamar dynamometer. The participant performs the test in a seated position with the elbow flexed at 90 degrees. Unit of Measure: Kilograms

  2. Pinch Strength

    Time frame: Baseline (single assessment at enrollment)

    Measured using a pinchmeter to assess tip-to-tip and key pinch strength. Unit of Measure: Kilograms

  3. Thumb Opposition (Kapandji Score)

    Time frame: Baseline (single assessment at enrollment)

    Assessment of thumb opposition using the Kapandji score, which ranges from 0 to 10. Higher scores indicate better thumb opposition and mobility.

  4. Pain Intensity

    Time frame: Baseline (single assessment at enrollment)

    Measured using a Visual Analog Scale (VAS) ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain intensity.

  5. Pain Duration

    Time frame: Baseline (single assessment at enrollment)

    Total duration of thumb pain reported by the participant.

  6. Radiographic Severity (Eaton-Littler Stage)

    Time frame: Baseline (single assessment at enrollment)

    Evaluation of the trapeziometacarpal joint osteoarthritis stage based on the Eaton-Littler classification (Stages I through IV).

  7. Radial Subluxation Ratio

    Time frame: Baseline (single assessment at enrollment)

    Radiographic measurement of the radial subluxation of the metacarpal base on the trapezium.

  8. Upper Extremity Disability (QuickDASH)

    Time frame: Baseline (single assessment at enrollment)

    Measured using the Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) questionnaire. The score ranges from 0 to 100, where higher scores indicate greater disability and symptoms.

  9. Hand Disability (Turkish Thumb Disability Index - TDX)

    Time frame: Baseline (single assessment at enrollment)

    Assessment of thumb-related disability. Scores range from 0 to 100, with higher scores indicating greater functional impairment.

  10. Joint Hypermobility (Beighton Score)

    Time frame: Baseline (single assessment at enrollment)

    Assessment of generalized joint laxity using the Beighton score. The total score ranges from 0 to 9, where higher scores indicate greater hypermobility.

  11. Thumb Joint Range of Motion

    Time frame: Baseline (single assessment at enrollment)

    Active range of motion of the thumb joints measured using a goniometer. Unit of Measure: Degrees

  12. Provocative Tests

    Time frame: Baseline (single assessment at enrollment)

    Clinical assessment using metacarpal adduction and extension tests to provoke symptoms. Presence or absence of pain (Binary: Yes/No)

  13. Environmental Factors: Social Support and Ergonomic Adaptations

    Time frame: Baseline (single assessment at enrollment)

    Qualitative assessment of the participant's family support and the presence of ergonomic adaptations in their daily environment.

  14. Emotional Status (Hospital Anxiety and Depression Scale)

    Time frame: Baseline (single assessment at enrollment)

    Measured using the Hospital Anxiety and Depression Scale (HADS), which consists of two subscales: Anxiety (HADS-A) and Depression (HADS-D). Each subscale ranges from 0 to 21, where higher scores indicate greater levels of anxiety or depression (worse outcome).

  15. Kinesiophobia Level (Tampa Scale of Kinesiophobia)

    Time frame: Baseline (single assessment at enrollment)

    Measured using the 17-item Tampa Scale of Kinesiophobia (TSK-17) to assess the fear of movement or re-injury. Total scores range from 17 to 68, where higher scores indicate greater kinesiophobia (worse outcome).

  16. Pain-Activity Patterns (Patterns of Activity Measure-Pain).

    Time frame: Baseline (single assessment at enrollment).

    Measured using the Patterns of Activity Measure-Pain (POAM-P) questionnaire to classify participants into three patterns: avoidance, overdoing, and pacing. Each subscale score indicates the frequency of that specific activity pattern. Higher scores on each subscale indicate a more frequent use of that specific activity pattern.

  17. Pain Beliefs Profile (Pain Beliefs Questionnaire)

    Time frame: Baseline (single assessment at enrollment).

    Assessed using the Pain Beliefs Questionnaire (PBQ), which evaluates two dimensions: Organic and Psychological pain beliefs. Scores range from 1 to 6 for each subscale, where higher scores indicate a stronger belief in that specific dimension (e.g., higher organic scores mean a stronger belief that pain is due to physical damage).

  18. Pain Coping Strategies (Pain Coping Questionnaire).

    Time frame: Baseline (single assessment at enrollment).

    Measured using the Pain Coping Questionnaire (PCQ) to assess the frequency of different coping strategies (e.g., information seeking, problem solving, distraction). Higher scores indicate a more frequent use of the respective coping strategy.

  19. Large Language Model Clinical Knowledge Accuracy

    Time frame: Baseline (single assessment during the data collection period)

    Performance comparison of four large language models (Claude, ChatGPT, Gemini, LLaMA) on 40 clinical questions. Evaluated by two independent blinded experts using a 4-point Likert scale (1: Completely Incorrect, 4: Completely Correct). Higher scores indicate better accuracy.

  20. Large Language Model Response Reproducibility

    Time frame: Within 24 hours after initial query

    Assessment of content consistency between two repeated queries of the same questions. Evaluated based on the percentage of agreement between the two sets of responses.

  21. Large Language Model Content Comprehensiveness

    Time frame: Baseline (single assessment at enrollment)

    Evaluation of how thoroughly the model covers the necessary clinical details. Measured on a 5-point scale (1: Very Poor, 5: Very Good). Higher scores indicate more comprehensive answers.

  22. Large Language Model Clinical Relevance

    Time frame: Baseline (single assessment)

    Assessment of the practical utility of the responses for clinical practice. Measured on a 5-point scale (1: Not Relevant, 5: Highly Relevant). Higher scores indicate greater clinical utility.

  23. Large Language Model Readability Score

    Time frame: Baseline (calculated immediately after response generation)

    The readability of the generated responses will be calculated using the Flesch Reading Ease Score. Scores typically range from 0 to 100, where higher scores indicate that the text is easier to read.

  24. LLM Prediction Accuracy for Continuous ICF Profiles

    Time frame: Within 3 months after the completion of clinical data collection.

    Prediction accuracy of the best-performing LLM (identified in WP2) in estimating continuous clinical scores (e.g., Grip Strength, QuickDASH scores) from core clinical predictors. Accuracy will be measured using the Intraclass Correlation Coefficient (ICC) to evaluate the agreement between LLM-predicted values and actual clinical assessment results.

  25. LLM Prediction Accuracy for Categorical ICF Profiles

    Time frame: Within 3 months after the completion of clinical data collection.

    Prediction accuracy of the best-performing LLM in estimating categorical patient profiles (e.g., Eaton-Littler Stage, POAM-P activity patterns). Accuracy will be measured using Cohen's Kappa coefficient to evaluate the agreement between LLM-predicted categories and actual expert-diagnosed categories.

Secondary outcomes

  1. Correlations Between Pain-Activity Patterns and Clinical Variables

    Time frame: Baseline (single assessment at enrollment)

    This measure evaluates the correlation between the subscale scores of the Patterns of Activity Measure-Pain (POAM-P) questionnaire (Avoidance, Overdoing, and Pacing) and clinical parameters, including pain intensity (VAS), grip strength (kg), upper extremity disability (QuickDASH), and emotional status (HADS). Correlation will be analyzed using Spearman's or Pearson's correlation coefficients depending on the data distribution. Unit of Measure: Correlation Coefficient

  2. Kinesiophobia Level (Tampa Kinesiophobia Scale)

    Time frame: Baseline (single assessment at enrollment).

    Level of fear of movement or re-injury will be assessed using the unabbreviated 17-item Tampa Scale of Kinesiophobia (TSK-17). Total scores range from a minimum of 17 to a maximum of 68. Higher scores indicate a greater level of kinesiophobia (worse outcome).

  3. Pain Beliefs Profile (Pain Beliefs Questionnaire)

    Time frame: Baseline (single assessment at enrollment)

    This measure assesses the patients' beliefs about the cause of their pain using the unabbreviated Pain Beliefs Questionnaire (PBQ). The PBQ consists of two subscales: Organic Beliefs and Psychological Beliefs. Each subscale score is evaluated, and their correlation with coping strategies and emotional status is analyzed. For each subscale, scores range from 1 to 6 (calculated as an average of items), where higher scores indicate a stronger belief in that specific dimension (e.g., higher organic scores mean a stronger belief that pain has a physical cause).

  4. Anxiety and Depression (Hospital Anxiety and Depression Scale)

    Time frame: Baseline (single assessment at enrollment).

    Emotional status will be assessed using the Hospital Anxiety and Depression Scale (HADS). The scale consists of two subscales: HADS-Anxiety (HADS-A) and HADS-Depression (HADS-D). Each subscale ranges from 0 to 21, where higher scores indicate greater levels of anxiety or depression (worse outcome).

  5. Pain Coping Strategies (Pain Coping Questionnaire)

    Time frame: Baseline (single assessment at enrollment)

    Evaluation of the various methods used by participants to manage their pain using the unabbreviated Pain Coping Questionnaire (PCQ). The questionnaire assesses different subscales such as Information Seeking, Problem Solving, and Distraction. Each subscale is scored, and higher scores indicate a more frequent use of that specific coping strategy (higher scores generally represent better or more active coping, depending on the specific subscale).

Study contacts

Contact information is provided by the study sponsor or research team.

Tugba Ulusoy, MSc

CONTACT

[email protected]

+90 5075097351

Sponsors and collaborators

Lead sponsor

Hacettepe University

Other

Registry information

Official study title

ICF-Based Biopsychosocial Assessment With Artificial Intelligence-Assisted Profile Prediction: Trapeziometacarpal Osteoarthritis Model

Acronym: ICF

Important dates

Study start
2026
Primary completion
2026
Study completion
2027
First posted
Mar 9, 2026
Registry last updated
Mar 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.